首页> 外国专利> MANAGEMENT OF ACUTE KIDNEY INJURY USING INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 AND TISSUE INHIBITOR OF METALLOPROTEINASE 2

MANAGEMENT OF ACUTE KIDNEY INJURY USING INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 AND TISSUE INHIBITOR OF METALLOPROTEINASE 2

机译:使用胰岛素样生长因子结合蛋白7和金属蛋白酶2的组织抑制剂来治疗急性肾损伤

摘要

The present invention provides methods and compositions for identifying patients at risk of kidney injury. A risk score, which is a composite of a urinary concentration of IGFBP7 (insulin-like growth factor-binding protein 7) and a urinary concentration of TIMP-2 (tissue inhibitor of metalloproteinase 2), is determined obtained from the patient, and is used to manage patient treatment.
机译:本发明提供了用于鉴定有肾损伤风险的患者的方法和组合物。确定患者的风险分数,该分数是尿液中IGFBP7(胰岛素样生长因子结合蛋白7)的浓度与尿液中TIMP-2(金属蛋白酶2的组织抑制剂)的浓度的总和。用于管理患者的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号